Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Top Cited Papers
Open Access
- 1 May 2009
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 182 (9) , 5693-5701
- https://doi.org/10.4049/jimmunol.0900092
Abstract
Myeloid-derived suppressor cells (MDSC) are a major component of the immune suppressive network described in cancer and many other pathological conditions. Recent studies have demonstrated that one of the major mechanisms of MDSC-induced immune suppression is mediated by reactive oxygen species (ROS). However, the mechanism of this phenomenon remained unknown. In this study, we observed a substantial up-regulation of ROS by MDSC in all of seven different tumor models and in patients with head and neck cancer. The increased ROS production by MDSC is mediated by up-regulated activity of NADPH oxidase (NOX2). MDSC from tumor-bearing mice had significantly higher expression of NOX2 subunits, primarily p47phox and gp91phox, compared with immature myeloid cells from tumor-free mice. Expression of NOX2 subunits in MDSC was controlled by the STAT3 transcription factor. In the absence of NOX2 activity, MDSC lost the ability to suppress T cell responses and quickly differentiated into mature macrophages and dendritic cells. These findings expand our fundamental understanding of the biology of MDSC and may also open new opportunities for therapeutic regulation of these cells in cancer.Keywords
This publication has 36 references indexed in Scilit:
- Modulation of the antitumor immune response by complementNature Immunology, 2008
- Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinThe Journal of Experimental Medicine, 2008
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell–suppressive activityBlood, 2008
- Mechanism of All-TransRetinoic Acid Effect on Tumor-Associated Myeloid-Derived Suppressor CellsCancer Research, 2007
- Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancerNature Medicine, 2007
- Altered macrophage differentiation and immune dysfunction in tumor developmentJournal of Clinical Investigation, 2007
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer PatientsCancer Research, 2006
- Mechanisms and functional significance of tumour-induced dendritic-cell defectsNature Reviews Immunology, 2004